| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1047102826 |
| P356 | DOI | 10.1186/S12944-015-0141-Z |
| P932 | PMC publication ID | 4668687 |
| P698 | PubMed publication ID | 26631018 |
| P5875 | ResearchGate publication ID | 285620392 |
| P2093 | author name string | Xin Xu | |
| Xiaolin Li | |||
| Nannan Zhang | |||
| Yongning Xin | |||
| Linlin Lu | |||
| Shiying Xuan | |||
| Quanyong Dong | |||
| P2860 | cites work | Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A | Q24530543 |
| Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome | Q28080989 | ||
| Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis | Q28085766 | ||
| Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level | Q28237301 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology | Q28267844 | ||
| The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. | Q46817068 | ||
| Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. | Q46880188 | ||
| Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. | Q48143160 | ||
| Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea | Q48538212 | ||
| Early signs of atherosclerosis in obstructive sleep apnea | Q48551584 | ||
| Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis | Q48635527 | ||
| How much is too much? Interleukin-6 and its signalling in atherosclerosis | Q50324473 | ||
| Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study | Q45069240 | ||
| Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. | Q45151844 | ||
| Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. | Q45261934 | ||
| Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. | Q45273943 | ||
| Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography. | Q45800509 | ||
| Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. | Q46002193 | ||
| Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. | Q46054421 | ||
| Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. | Q46648387 | ||
| Serum retinol-binding protein 4 as a marker for cardiovascular disease in women | Q28484681 | ||
| Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis | Q29619888 | ||
| Long-term follow-up of patients with NAFLD and elevated liver enzymes | Q29620024 | ||
| Epidemiology of non-alcoholic fatty liver disease in China. | Q30373353 | ||
| Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients | Q33308506 | ||
| Pathogenesis of non-alcoholic fatty liver disease. | Q33606303 | ||
| Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure | Q33717545 | ||
| Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
| Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
| Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. | Q34099171 | ||
| Adiponectin abates atherosclerosis by reducing oxidative stress | Q34338139 | ||
| Fatty acid-binding proteins as plasma markers of tissue injury | Q34384710 | ||
| Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. | Q34436367 | ||
| High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway | Q34455345 | ||
| Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease | Q34479731 | ||
| Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis | Q34485931 | ||
| Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 | ||
| Obstructive sleep apnoea and its cardiovascular consequences | Q34909223 | ||
| Intima-media thickness: a tool for atherosclerosis imaging and event prediction | Q35013010 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates | Q35133872 | ||
| Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease | Q35602513 | ||
| Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential | Q35614922 | ||
| High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects | Q35688347 | ||
| OSA and atherosclerosis | Q36042326 | ||
| Non-alcoholic fatty liver disease and increased risk of cardiovascular disease | Q36592831 | ||
| Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications | Q36617551 | ||
| Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients | Q36727795 | ||
| Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. | Q36845502 | ||
| Obesity and nonalcoholic fatty liver disease | Q36867151 | ||
| Fatty liver: a novel component of the metabolic syndrome | Q36906553 | ||
| Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. | Q50730228 | ||
| Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. | Q50994204 | ||
| Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease. | Q51303995 | ||
| Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. | Q51350044 | ||
| The association of serum chemerin level with risk of coronary artery disease in Chinese adults. | Q51366030 | ||
| Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. | Q51423127 | ||
| Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. | Q51970541 | ||
| Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. | Q53296244 | ||
| Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. | Q53610443 | ||
| Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. | Q53842501 | ||
| Resistin is an inflammatory marker of atherosclerosis in humans. | Q53870894 | ||
| Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats. | Q54354142 | ||
| Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population | Q61718679 | ||
| Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study | Q73250259 | ||
| Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction | Q73615780 | ||
| Non-alcoholic fatty liver disease | Q74052826 | ||
| Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary | Q80470858 | ||
| Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis | Q80473282 | ||
| Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial infarction | Q81687207 | ||
| Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis | Q83020803 | ||
| Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 | Q83161496 | ||
| Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction | Q83745670 | ||
| Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease | Q83864225 | ||
| [Reactive oxygen species and oxidative stress] | Q83981816 | ||
| Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients | Q84006151 | ||
| Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD | Q84971455 | ||
| Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD) | Q84992868 | ||
| [Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease] | Q85011261 | ||
| Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases | Q85393510 | ||
| Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness | Q86156689 | ||
| Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction | Q86851337 | ||
| Obesity and free fatty acids | Q37001269 | ||
| Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease | Q37002532 | ||
| Mechanisms of disease progression in nonalcoholic fatty liver disease | Q37310288 | ||
| Study of coronary atherosclerosis by modified american heart association classification of atherosclerosis-an autopsy study | Q37429415 | ||
| Role of gut microbiota in liver diseases | Q37488165 | ||
| Endotoxemia and gut barrier dysfunction in alcoholic liver disease | Q37539842 | ||
| Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis | Q37698287 | ||
| The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease | Q37736540 | ||
| Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. | Q37771540 | ||
| Atherosclerosis regression and high-density lipoproteins | Q37786650 | ||
| Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | Q37794163 | ||
| Morphological aspects of atherosclerosis lesion: past and present | Q37861924 | ||
| Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects | Q37882523 | ||
| NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages | Q37935278 | ||
| Fetuin-A and the cardiovascular system. | Q37991344 | ||
| Metabolic syndrome and risk factors for non-alcoholic fatty liver disease | Q38000540 | ||
| Latest advances in sleep medicine: obstructive sleep apnea | Q38064776 | ||
| Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis | Q38087926 | ||
| Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 | ||
| Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling | Q38323825 | ||
| Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis | Q39484186 | ||
| Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment | Q39660255 | ||
| Dihydrotestosterone protects human vascular endothelial cells from H(2)O(2)-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK. | Q39685042 | ||
| Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells | Q39759186 | ||
| NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model | Q39861568 | ||
| Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization | Q40174095 | ||
| Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients | Q40370241 | ||
| Plasma leptin and prognosis in patients with established coronary atherosclerosis. | Q40471451 | ||
| Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. | Q40569748 | ||
| Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet | Q40597623 | ||
| Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors | Q41209308 | ||
| Non-alcoholic fatty liver disease is associated with progression of arterial stiffness | Q41747504 | ||
| A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease | Q42109041 | ||
| Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease | Q42246177 | ||
| Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation | Q42284823 | ||
| Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance | Q42832316 | ||
| Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. | Q42870878 | ||
| Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels | Q43156391 | ||
| Disturbances of lipoprotein metabolism in metabolic syndrome | Q43186513 | ||
| Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease | Q43287084 | ||
| Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue | Q43330487 | ||
| Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. | Q43833573 | ||
| Effect of recombinant human growth hormone on postoperative fatigue syndrome in patients after cardiac operations | Q44070117 | ||
| NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability | Q44739231 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | clinical chemistry | Q849994 |
| liver disease | Q929737 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| atherosclerosis | Q12252367 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 158 | |
| P577 | publication date | 2015-12-03 | |
| P1433 | published in | Lipids in Health and Disease | Q15756695 |
| P1476 | title | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis | |
| P478 | volume | 14 |
| Q38597776 | 2, 3, 4', 5-tetrahydroxystilbene-2-0-β-D glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport |
| Q91787897 | Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation |
| Q55516162 | Alleviation of diabetic complications by ginsenoside Rg3-enriched red ginseng extract in western diet-fed LDL-/- mice. |
| Q47095883 | Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats |
| Q60045998 | Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model |
| Q92006171 | Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque |
| Q26738524 | Herbal medicines and nonalcoholic fatty liver disease |
| Q45305677 | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis |
| Q96607203 | Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice |
| Q58722876 | Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects |
| Q28071957 | Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer |
| Q49960681 | RGC-32 (Response Gene to Complement 32 Protein) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis |
| Q41989611 | The influence of different diets on metabolism and atherosclerosis processes-A porcine model: Blood serum, urine and tissues 1H NMR metabolomics targeted analysis |
Search more.